06.11.2015
RHÖN-KLINIKUM AG DE0007042301
DGAP-News: RHÖN-KLINIKUM AG: Interim Report for the Third Quarter: Business Development as Plannes - Second Share Repurchase - Scheme Completed - New Departmental Responsibilities for the Management Board
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Quarter Results/Quarter
Results
RHÖN-KLINIKUM AG: Interim Report for the Third Quarter: Business
Development as Plannes - Second Share Repurchase - Scheme Completed -
New Departmental Responsibilities for the Management Board
06.11.2015 / 07:00
---------------------------------------------------------------------
Corporate News
RHÖN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt/Saale
www.rhoen-klinikum-ag.com
Interim Report for the Third Quarter:
- RHÖN-KLINIKUM AG Business Development as Planned
- Second Share Repurchase Scheme Completed
- New Departmental Responsibilities for the Management Board
- 569,978 patients treated
- Revenues amount to EUR 832.0 million
- EBITDA stands at EUR 117.3 million
- Outlook for 2015 remains unchanged: revenues between EUR 1.08 billion
and EUR 1.12 billion,EBITDA between EUR 145 million and EUR 155
million
Bad Neustadt / Saale, 6th November 2015
RHÖN-KLINIKUM AG's operative business progressed as planned in the first
nine months of the current financial year. A total of 569,978 patients were
treated in the company's hospitals during this period. Revenues for the
period from January up to and including September amounted to EUR 832.0
million and earnings before interest, taxes, depreciation and amortisation
(EBITDA) stood at EUR 117.3 million. These financial figures are not
directly comparable with those of previous years due to the sale of a total
of 43 facilities which was completed during last financial year 2014.
Successful Completion of Second Share Repurchase Scheme
The second share repurchase scheme ended on 8th October 2015. The public
purchase offer was accepted for a total of 6,519,390 RHÖN KLINIKUM shares
at a share price of EUR 25.54 which corresponds to approx. 9 % of the total
share capital issued on the cut-off date and a volume of approx. EUR 167
million. With its new financial structure the corporate group can now
embrace more purposefully the requirements of resource management
orientated to capital costs and is therefore in a better position to be
able to take advantage of business opportunities for further development.
Larger Board of Management, Modified Departmental Responsibilities and
Standardised Contractual Terms
The company's Board of Management will be enlarged with effect from 1st
January 2016. Prof. Dr. Bernd Griewing, spokesperson for the Medical Board
and Medical Director of the Neurological Clinic in Bad Neustadt, has been
appointed to the executive body by the Supervisory Board as the Chief
Medical Officer (CMO) alongside Dr. Martin Siebert (CEO), Jens-Peter
Neumann (CFO) and Martin Menger (COO). The departmental responsibilities of
the Board of Management have also been modified and the terms of the
service agreements of the Board of Management standardised; all the members
will now receive a five-year agreement, each starting on 1st January 2016.
Outlook
We continue to expect revenues of EUR 1.08 billion to EUR 1.12 billion and
EBITDA of between EUR 145 million and EUR 155 million for 2015, the first
full financial year with the new portfolio structure. As in previous years
one-off effects will continue to influence the corporate results during
this financial year as well. These positive and negative special influences
will occur during the entire financial year 2015, their size is a low
two-digit million figure and they will partially cancel each other out.
"We are continuing to press ahead with the extensive implementation of our
corporate strategy with targeted investments in the building structures and
medical equipment of our hospitals, systematically linking medicine and
nursing to each other and also realising synergies," CEO Dr. Martin Siebert
said. "Our focus on healthcare which is orientated to maximum medical care
and has a direct link to universities is also reflected in the new
structure of the Board of Management: with a larger Board and modified
departmental responsibilities we have now created the preconditions for
consistent further development of the larger medical concepts of the
future, such as e-health, ensuring high-quality medical care in rural areas
and extending medical networks to provide excellent healthcare services
further afield. This will benefit our patients, employees and shareholders
alike," Siebert continued.
**************************************************************************
RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany.
With ten hospitals in five locations and a total of roughly 5,300 beds we
offer affordable cutting-edge medical care with a direct link to
universities and research institutes. Our facilities are located in Bad
Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. A
total of over 15,000 employees work for RHÖN-KLINIKUM AG.
Further information is available at: www.rhoen-klinikum-ag.com.
Your Contact Persons:
RHÖN-KLINIKUM AG
Achim Struchholz
Head of Corporate Communication
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1327
Facsimile: + 49 - 9771 65-1820
E-Mail: [email protected]
Dr. Kai G. Klinger
Head of Investor Relations & Group Financing
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1318
Facsimile: + 49 - 9771 99-1736
E-Mail: [email protected]
---------------------------------------------------------------------
06.11.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart
End of News DGAP News Service
---------------------------------------------------------------------
409759 06.11.2015
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
RHÖN-KLINIKUM AG ISIN: DE0007042301 können Sie bei EQS abrufen
Pflegeeinrichtungen , 704230 , RHK , XETR:RHK